Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 35.

Basler, L; Andratschke, N; Ehrbar, S; Guckenberger, M; Tanadini-Lang, S (2018). Modelling the immunosuppressive effect of liver SBRT by simulating the dose to circulating lymphocytes: an in-silico planning study. Radiation Oncology, 13(1):10.

Krayenbuehl, J; Di Martino, M; Guckenberger, M; Andratschke, N (2017). Correction to: Improved plan quality with automated radiotherapy planning for whole brain with hippocampus sparing: a comparison to the RTOG 0933 trial. Radiation Oncology, 12(1):173.

Krayenbuehl, J; Di Martino, M; Guckenberger, M; Andratschke, N (2017). Improved plan quality with automated radiotherapy planning for whole brain with hippocampus sparing: a comparison to the RTOG 0933 trial. Radiation Oncology, 12(1):161.

Gkika, E; Tanadini-Lang, S; Kirste, S; Holzner, P A; Neeff, H P; Rischke, H C; Reese, T; Lohaus, F; Duma, M N; Dieckmann, K; Semrau, R; Stockinger, M; Imhoff, D; Kremers, N; Häfner, M F; Andratschke, N; Nestle, U; Grosu, A L; Guckenberger, M; Brunner, T B (2017). Interobserver variability in target volume delineation of hepatocellular carcinoma : An analysis of the working group "Stereotactic Radiotherapy" of the German Society for Radiation Oncology (DEGRO). Strahlentherapie und Onkologie, 193(10):823-830.

Basler, L; Kroeze, S G C; Guckenberger, M (2017). SBRT for oligoprogressive oncogene addicted NSCLC. Lung Cancer, 106:50-57.

Klement, R J; Guckenberger, M; Alheid, H; Allgäuer, M; Becker, G; Blanck, O; Boda-Heggemann, J; Brunner, T; Duma, M; Gerum, S; Habermehl, D; Hildebrandt, G; Lewitzki, V; Ostheimer, C; Papachristofilou, A; Petersen, C; Schneider, T; Semrau, R; Wachter, S; Andratschke, N (2017). Stereotactic body radiotherapy for oligo-metastatic liver disease - Influence of pre-treatment chemotherapy and histology on local tumor control. Radiotherapy and Oncology, 123(2):227-233.

Tanadini-Lang, S; Rieber, J; Filippi, A R; Fode, M M; Streblow, J; Adebahr, S; Andratschke, N; Blanck, O; Boda-Heggemann, J; Duma, M; Eble, M J; Ernst, I; Flentje, M; Gerum, S; Hass, P; Henkenberens, C; Hildebrandt, G; Imhoff, D; Kahl, H; Klass, N D; Krempien, R; Lohaus, F; Petersen, C; Schrade, E; Wendt, T G; Wittig, A; Høyer, M; Ricardi, U; Sterzing, F; Guckenberger, M (2017). Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease. Radiotherapy and Oncology, 123(2):182-188.

Roesch, J; Panje, C; Sterzing, F; Mantel, F; Nestle, U; Andratschke, N; Guckenberger, M (2016). SBRT for centrally localized NSCLC - What is too central? Radiation Oncology, 11(1):157.

Bogowicz, M; Riesterer, O; Bundschuh, R A; Veit-Haibach, P; Hüllner, M; Studer, G; Stieb, S; Glatz, S; Pruschy, M; Guckenberger, M; Tanadini-Lang, S (2016). Stability of radiomic features in CT perfusion maps. Physics in Medicine and Biology, 61(24):8736-8749.

Ghadjar, P; Hyoz, S; Bernhard, J; Zwahlen, D; Holscher, T; Gut, P; Guckenberger, M; Hildebrandt, G; Muller, A; Plasswilm, J; Papachristofilou, A; Stalder, L; Biaggi-Rudolf, C; Sumila, M; Kranzbuhler, H; Najafi, Y; Ost, P; Azinwi, N; Reuter, C; Bodis, S; Kaouthar, K; Wust, P; Thalmann, G; Aebersold, D (2015). Acute toxicity and quality of life after dose-intensified salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy: first results of the randomized trial SAKK 09/10. Journal of Clinical Oncology, 33(35):4158-4166.

Guckenberger, M; Riesterer, O; Theile, G; Andratschke, N (2015). Herausforderungen und Chancen in der radioonkologischen Behandlung von Patienten im Alter. Schweizer Krebs-Bulletin, 35(3):257-260.

Adebahr, S; Collette, S; Shash, E; Lambrecht, M; Le Pechoux, C; Faivre-Finn, C; De Ruysscher, D; Peulen, H; Belderbos, J; Dziadziuszko, R; Fink, C; Guckenberger, M; Hurkmans, C; Nestle, U (2015). Stereotactic body radiotherapy for central lung tumours: Author reply. British Journal of Radiology, 88(1053):2 pages.

Adebahr, S; Collette, S; Shash, E; Lambrecht, M; Le Pechoux, C; Faivre-Finn, C; De Ruysscher, D; Peulen, H; Belderbos, J; Dziadziuszko, R; Fink, C; Guckenberger, M; Hurkmans, C; Nestle, U (2015). LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective. British Journal of Radiology, 88(1051):15.

Schanne, D H; Nestle, U; Allgaeuer, M; Andratschke, N; Appold, S; Dieckmann, U; Ernst, I; Ganswindt, U; Grosu, A L; Holy, R; Molls, M; Nevinny-Stickel, M; Semrau, S; Sterzing, F; Wittig, A; Guckenberger, M (2015). Stereotactic body radiotherapy for centrally located stage I NSCLC: a multicenter analysis. Strahlentherapie und Onkologie, 191(2):125-132.

Guckenberger, M; Riesterer, O; Andratschke, N (2015). Extrakranielle Stereotaxie von Leber- und Pankreas Tumoren. info@onkologie, 1(2015):24-30.

Roesch, J; Guckenberger, M; Riesterer, O (2015). Individualisierte Radiotherapie des Pleuramesothelioms. Schweizer Zeitschrift für Onkologie, (4):24-30.

Guckenberger, M (2015). Präoperative Kurzzeitradiotherapie kombiniert mit volldosierter Langzeitchemotherapie beim lokal fortgeschrittenen Rektumkarzinom. Das Beste aus zwei Welten. Strahlentherapie und Onkologie, 191(3):285-287.

Linsenmeier, C; Guckenberger, M (2015). Radiotherapie nach brusterhaltender Operation. Wohin geht der Weg. Leading Opinions Hämatologie & Onkologie, 2(15):78-80.

Guckenberger, M (2015). Stereotactic Body Radiotherapy for Stage I NSCLC. In: Peters, S; Bresse, B. New Therapeutic Strategies in Lung Cancers. Cham: Springer, 33-48.

Guckenberger, M (2015). Value of Patient Immobilization in External Beam Radiotherapy for Prostate Cancer. In: Geinitz, H; Roach III, M; Van As, N. Radiotherapy in Prostate Cancer : Innovative Techniques and Current Controversies. Berlin / Heidelberg: Springer, 41-44.

Chan, C; Lang, S; Rowbottom, C; Guckenberger, M; Faivre-Finn, C (2014). Intensity-modulated radiotherapy for lung cancer: current status and future developments. Journal of Thoracic Oncology, 9(11):1598-1608.

Sterzing, F; Brunner, T B; Ernst, I; Baus, W W; Greve, B; Herfarth, K; Guckenberger, M (2014). Stereotactic body radiotherapy for liver tumors: Principles and practical guidelines of the DEGRO Working Group on Stereotactic Radiotherapy. Strahlentherapie und Onkologie, 190(10):872-881.

Guckenberger, M (2014). Stellenwert der 5-FU-basierten adjuvanten Chemotherapie nach präoperativer Radiochemotherapie beim lokal fortgeschrittenen Rektumkarzinom. 10-Jahresergebnisse der EORTC-22921-Studie. Strahlentherapie und Onkologie, 190(8):772-773.

Klement, R J; Allgaeuer, M; Appold, S; Dieckmann, K; Ernst, I; Ganswindt, U; Holy, R; Nestle, U; Nevinny-Stickel, M; Semrau, S; Sterzing, F; Wittig, A; Andratschke, N; Guckenberger, M (2014). Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer. International Journal of Radiation Oncology, Biology, Physics, 88(3):732-738.

Kestin, L; Grills, I; Guckenberger, M; Belderbos, J; Hope, A J; Werner-Wasik, M; Sonke, J J; Bissonnette, J P; Xiao, Y; Yan, D (2014). Dose-response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance. Radiotherapy and Oncology, 110(3):499-504.

Mueller, K; Schlamann, A; Guckenberger, M; Warmuth-Metz, M; Glueck, A; Pietschmann, S; Wawer, A; Kortmann, R D; Kramm, C; von Bueren, A O (2014). Craniospinal irradiation with concurrent temozolomide for primary metastatic pediatric high-grade or diffuse intrinsic pontine gliomas. A first report from the GPOH-HIT-HGG Study Group. Strahlentherapie und Onkologie, 190(4):377-381.

Mantel, F; Glatz, S; Toussaint, A; Flentje, M; Guckenberger, M (2014). Long-term safety and efficacy of fractionated stereotactic body radiation therapy for spinal metastases. Strahlentherapie und Onkologie, 190(12):1141-1148.

Guckenberger, M; Sweeney, R A (2014). Spinal Radiosurgery after Radiation Therapy XRT or Radiosurgery. In: Sheehan, J P; Gerszten, P C. Controversies in Stereotactic Radiosurgery : Best Evidence Recommendations. New York: Thieme Medical Publishers, 162-170.

Senan, S; Ricardi, U; Guckenberger, M (2014). Stage I non-small cell lung cancer and oligometastatic disease. In: Pass, H I; Ball, D; Scagliotti, G V. The IASLC Multidisciplinary Approach to Thoracic Oncology. USA-Aurora, Colorado: IASLC, 479-494.

Guckenberger, M (2014). Stereotactic body radiotherapy for stage I NSCLC: The challenge of evidence-based medicine. Journal of Thoracic Oncology, 9(2):E17-E18.

Kocher, M; Wittig, A; Piroth, M D; Treuer, H; Seegenschmiedt, H; Ruge, M; Grosu, A L; Guckenberger, M (2014). Stereotactic radiosurgery for treatment of brain metastases. Strahlentherapie und Onkologie, 190(6):521-532.

Guckenberger, M; Andratschke, N (2014). Stereotaktische Bestrahlung - Lokale Tumorkontrolle enorm verbessert. Deutsches Ärzteblatt, 111(45):20-21.

Riesterer, O; Guckenberger, M (2014). Stereotaktische Strahlentherapie von Metastasen : Palliativer Effekt und Tumorkontrolle. Onkologe, 20(8):757-765.

Serpa, M; Baier, K; Cremers, F P M; Guckenberger, M; Meyer, J (2014). Suitability of markerless EPID tracking for tumor position verification in gated radiotherapy. Medical Physics, 41(3):031702.

Sassowsky, M; Gut, P; Hölscher, T; Hildebrandt, G; Müller, A C; Najafi, Y; Kohler, G; Kranzbühler, H; Guckenberger, M; Zwahlen, D R; Azinwi, N C; Plasswilm, L; Takacs, I; Reuter, C; Sumila, M; Manser, P; Ost, P; Böhmer, D; Pilop, C; Aebersold, D M; Ghadjar, P (2013). Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10. International Journal of Radiation Oncology, Biology, Physics, 87(3):534-541.

This list was generated on Wed Aug 22 10:01:37 2018 CEST.